Related Experiment Video
Updated: Jul 30, 2026

07:13
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
[Athyreotic congenital hypothyroidism in two sisters]
Summary
Athyreotic congenital hypothyroidism, a rare condition, was diagnosed in two sisters. Early thyroxine replacement therapy ensured normal physical and psychological development, suggesting a potential genetic basis.
Area of Science:
- Endocrinology
- Genetics
- Pediatrics
Background:
- Congenital hypothyroidism (CH) is a common endocrine disorder in newborns.
- Athyreotic CH, characterized by the absence of a thyroid gland, is a severe form of CH.
- Early diagnosis and treatment are crucial for normal development.
Observation:
- Two sisters presented with symptoms of CH, including jaundice, abdominal distention, and constipation.
- Both patients exhibited low serum thyroxine (T4) and markedly elevated serum thyroid-stimulating hormone (TSH) levels.
- Thyroid scintigraphy revealed no iodine uptake, confirming an athyreotic state, with normal iodine transport.
Findings:
- The diagnosis of athyreotic congenital hypothyroidism was confirmed in both siblings.
- Despite the absence of a family history or parental consanguinity, a genetic factor is suspected.
- The patients have shown normal physical and psychological development with consistent thyroxine replacement therapy.
Implications:
- This case report highlights the importance of recognizing CH symptoms in the absence of neonatal screening.
- The sibling occurrence suggests a potential genetic etiology for athyreotic CH.
- Timely intervention with thyroxine therapy is vital for preventing developmental deficits in affected children.
Related Concept Videos
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

